Google on board for next-gen glucose monitoring for diabetics

Life sciences teams up with DexCom for smaller and less expensive devices
Wareable is reader-powered. If you click through using links on the site, we may earn an affiliate commission. Learn more

Google, Alphabet, whatever the company that Larry and Sergey built is called now, is pushing the boundaries in a wide range of technology fields.

One such area is medical science. Back in May we told you about a health-tracking wristband that could be used in clinical trials and drug tests; measuring things like pulse, hearth rhythm, skin temperature, light exposure and noise levels.

911 tech: Wearables that could save your life

The guys working on that, the life sciences team, have now announced they have teamed up with DexCom, a San Diego based company that specialises in developing continuous glucose monitoring (CGM) systems for use by people with diabetes.

The partnership is planning on creating next-generation CGM products that are both smaller and less expensive than what is currently on offer, with a focus on body worn devices. The end goal is disposable bandage-sized sensors that connect to the cloud, with real-time metrics.

"This partnership has the potential to change the face of diabetes technology forever," said Kevin Sayer, CEO of DexCom. "Working together, we believe we can introduce products that will move us beyond our core Type 1 business to become the standard of care for all people living with diabetes."

"We're committed to developing new technologies that will help move health care from reactive to proactive," added Andrew Conrad, head of the life sciences team at Google. "This collaboration is another step towards expanding monitoring options and making it easier for people with diabetes to proactively manage their health."

Medical grade wearables

Google on board for next-gen glucose monitoring for diabetics

With wearable devices now able to track and monitor a huge plethora of personal information, the lines between medical and consumer devices are becoming more blurred - hence the FDA publishing some guidelines to distinguish between the two, back in January.

"A general wellness product, for the purposes of this guidance, has (1) an intended use that relates to a maintaining or encouraging a general state of health or a healthy activity, or (2) an intended use claim that associates the role of healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or conditions and where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition."

Google's latest ventures would, of course, require FDA approval but this is not a new thing for the search giant to deal with.

Its incredibly futuristic, and potentially life-changing, smart contact lens was announced back in 2014 and the company stated it was already "in discussions with the FDA".

Google on board for next-gen glucose monitoring for diabetics

How we test

Paul Lamkin


Wareable Media Group co-CEO Paul launched Wareable with James Stables in 2014, after working for a variety of the UK's biggest and best consumer tech publications including Pocket-lint, Forbes, Electric Pig, Tech Digest, What Laptop, T3 and has been a judge for the TechRadar Awards. 

Prior to founding Wareable, and subsequently The Ambient, he was the senior editor of MSN Tech and has written for a range of publications.

Related stories